Eli Lilly And Co (1LLY) Stock Price & News

Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union army veteran during the American Civil War for whom the company was later named. The company is ranked 4th on the list of largest biomedical companies by revenue and is the most valuable pharmaceutical company worldwide. It is ranked 100th on the Fortune 500 and 138th on the Forbes Global 2000. In November 2025, the company reached a $1 trillion market capitalization, the first health-care company in the world to do so. The company's primary products are tirzepatide for the treatment of type 2 diabetes, weight loss, and obstructive sleep apnea; abemaciclib for the treatment of advanced or metastatic breast cancers; dulaglutide for the treatment of type 2 diabetes; ixekizumab for the treatment of autoimmune diseases; and empagliflozin for the treatment of type 2 diabetes. Wikipedia

About Eli Lilly And Co

CEOდეივიდ ეი რიკსი

Employees50 ათ.

Founded1876

Headquartersინდიანაპოლისი, ინდიანა, ამერიკის შეერთებული შტატები

SectorPharmaceutical industry

Websitelilly.com

Revenue

Net income

All values in USD	სექ. 2025	დეკ. 2025	მარ. 2026	ივნ. 2026
Revenue	17,60 მლრდ.	19,29 მლრდ.	19,80 მლრდ.	22,97 მლრდ.
Cost of goods sold	3,01 მლრდ.	3,37 მლრდ.	3,58 მლრდ.	3,27 მლრდ.
Cost of revenue	3,01 მლრდ.	3,37 მლრდ.	3,58 მლრდ.	3,27 მლრდ.
Research and development expenses	3,47 მლრდ.	3,80 მლრდ.	3,51 მლრდ.	3,82 მლრდ.
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	2,63 მლრდ.	3,46 მლრდ.	2,93 მლრდ.	3,43 მლრდ.
Operating expense	6,09 მლრდ.	7,26 მლრდ.	6,44 მლრდ.	7,25 მლრდ.
Total operating expenses	9,10 მლრდ.	10,63 მლრდ.	10,02 მლრდ.	10,52 მლრდ.
Operating income	8,50 მლრდ.	8,66 მლრდ.	9,78 მლრდ.	12,46 მლრდ.
Other non operating income	-9,10 მლნ.	181,20 მლნ.	170,00 მლნ.	561,00 მლნ.
EBT including unusual items	7,23 მლრდ.	8,27 მლრდ.	8,85 მლრდ.	9,25 მლრდ.
EBT excluding unusual items	8,21 მლრდ.	8,89 მლრდ.	9,71 მლრდ.	12,73 მლრდ.
Income tax expense	1,65 მლრდ.	1,63 მლრდ.	1,45 მლრდ.	2,15 მლრდ.
Effective tax rate	22,81%	19,70%	16,43%	23,27%
Other operating expenses	-	-	-	-
Net income	5,58 მლრდ.	6,64 მლრდ.	7,40 მლრდ.	7,10 მლრდ.
Net profit margin	31,72%	34,41%	37,36%	30,88%
Earnings per share	7,02	7,54	8,55	8,38
Interest and investment income	65,00 მლნ.	672,40 მლნ.	-	-
Interest expense	-179,60 მლნ.	-153,30 მლნ.	-332,00 მლნ.	-345,00 მლნ.
Net interest expenses	-114,60 მლნ.	519,10 მლნ.	-332,00 მლნ.	-345,00 მლნ.
Depreciation and amortization charges	-	-	-	-
EBITDA	8,97 მლრდ.	9,25 მლრდ.	10,29 მლრდ.	12,99 მლრდ.
Gain or loss from assets sale	-	-180,00 მლნ.	-	-

Finance

Ask anything